Citigroup Inc Coherus Bio Sciences, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Citigroup Inc holds 518,803 shares of CHRS stock, worth $788,580. This represents 0.0% of its overall portfolio holdings.

Number of Shares

518,803

Previous 464,455 11.7%

Holding current value

$788,580

Previous $803,000 32.88%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$0.99 - $1.8 $53,804 - $97,826	54,348 Added 11.7%	518,803 $539,000
Q2 2024 Aug 12, 2024	SELL	$1.58 - $2.51 $82,572 - $131,175	-52,261 Reduced 10.11%	464,455 $803,000
Q1 2024 May 10, 2024	BUY	$2.02 - $3.14 $288,676 - $448,734	142,909 Added 38.23%	516,716 $1.23 Million
Q4 2023 Feb 09, 2024	SELL	$1.59 - $3.85 $673,349 - $1.63 Million	-423,490 Reduced 53.12%	373,807 $1.24 Million
Q3 2023 Nov 09, 2023	BUY	$3.74 - $5.45 $1.08 Million - $1.58 Million	289,194 Added 56.92%	797,297 $2.98 Million
Q2 2023 Aug 10, 2023	SELL	$3.79 - $8.3 $1.37 Million - $3 Million	-361,210 Reduced 41.55%	508,103 $2.17 Million
Q1 2023 May 11, 2023	BUY	$5.89 - $10.52 $602,128 - $1.08 Million	102,229 Added 13.33%	869,313 $5.95 Million
Q4 2022 Feb 09, 2023	SELL	$5.69 - $10.07 $401,890 - $711,254	-70,631 Reduced 8.43%	767,084 $6.08 Million
Q3 2022 Nov 10, 2022	BUY	$7.17 - $13.87 $487,667 - $943,368	68,015 Added 8.84%	837,715 $8.05 Million
Q2 2022 Aug 10, 2022	BUY	$5.86 - $13.23 $497,560 - $1.12 Million	84,908 Added 12.4%	769,700 $5.57 Million
Q1 2022 May 12, 2022	SELL	$10.92 - $16.41 $1.2 Million - $1.8 Million	-109,604 Reduced 13.8%	684,792 $8.84 Million
Q4 2021 Feb 10, 2022	BUY	$15.81 - $18.99 $2.39 Million - $2.87 Million	151,196 Added 23.51%	794,396 $12.7 Million
Q3 2021 Nov 10, 2021	BUY	$12.68 - $17.79 $8.16 Million - $11.4 Million	643,200 New	643,200 $10.3 Million

Others Institutions Holding CHRS

# of Institutions

135

Shares Held

77.9M

Call Options Held

40.7K

Put Options Held

50.1K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $118M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account